Abstract Body

The interplay between innate immune responses of hepatocytes to HBV in the setting of ongoing HIV-1 replication require in vivo model system, and the underlying mechanisms by which HBV-induced liver pathogenesis, and mechanisms by which HIV co-infection accelerate that process remain unknown due in large part to the lack of small animal models. Such model is crucial for the development of novel therapies, treating HBV/HIV-coinfections and associated liver diseases. There are several unresolved problems in mice co-transplanted with human hepatocytes and immune cells: transplantation of mismatched by HLA genotypes hepatocytes and hematopoietic stem cells contain a risk for allograft rejection and the low functionality of adaptive immune responses. We hypothesize that human hepatocyte transplanted mice, infected with HBV and co-transplanted with human HIV-1 infected or uninfected macrophages will reproduce the features of viral interaction.

TK-NOG mice were transplanted with human hepatocytes, and after confirmation of the human albumin concentration in peripheral blood, animals were infected with HBV 107 GE/mouse (subtype D [i]ayw[/i]). Following confirmation of HBV DNA presence in peripheral blood (~1.5×10[sup]4[/sup] copies/ml), animals were injected with human monocyte-derived macrophages (MDM) or HIV-exposed MDM (5×10[sup]6[/sup] cells/mouse i.p.) and controls kept without MDM. Animals were observed for 51 days and levels of HIV RNA, HBV DNA, HBsAg in plasma were monitored. At end-point liver tissues were analyzed for histopathology, presence of viruses and human MDM by RT-PCR, and staining for human cells and viral proteins.

Multiphasic HBV viral kinetics – increase HBV DNA by day 13 and decline by day 51 in the presence of MDM, and exponential increase in HIV viral load were observed in the blood reaching steady levels at ~106 copies/ml by day 38. The plasma levels of HBsAg concentration also peaked at this point. Mice with HBV+HIV-MDM had higher content of HBV DNA, HIVgag RNA and human CD45 transcripts. Human hepatocytes in HBV infected mice showed strong expression of human HLA-DR, and proliferation. The plasma albumin concentration increased two folds in coinfected animals.

This study utilizes a novel humanized mouse model which will fill the critical knowledge gaps on the mechanism by which HBV/HIV co-infection accelerates liver diseases and is the first model to observe changes in both viral replication pattern and tissue histopathology.